During investigations of the AKT signaling more and more evidence raised that the three isoforms AKT1 (PKBα), AKT2 (PKBβ) and AKT3 (PKBγ) exert distinct and partly even opposing effects in cancer and physiologically. This evidence concerns the gene AKT1 and cancer.